ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Dantas-Torres F, 2007. Rocky Mountain spotted fever. Lancet Infect Dis 150: 480–488.
-
2.
Tennessee Department of Health, 2016. Reportable Diseases and Events Matrix. Available at: https://apps.health.tn.gov/ReportableDiseases/Common/Updated_ReportableDiseasesMatrix_160203.pdf. Accessed July 28, 2016.
-
3.
Drexler NA, Dahlgren FS, Heitman KN, Massung RF, Paddock CD, Behravesh CB, 2016. National surveillance of spotted fever group rickettsioses in the United States, 2008–2012. Am J Trop Med Hyg 94: 26–34.
-
4.
Openshaw JJ, Swerdlow DL, Krebs JW, Holman RC, Mandel E, Harvey A, Haberling D, Massung RF, McQuiston JH, 2010. Rocky Mountain spotted fever in the United States, 2000–2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg 83: 174–182.
-
5.
Dahlgren FS, Holman RC, Paddock CK, Callinan LS, McQuiston JH, 2012. Fatal Rocky Mountain spotted fever in the United States, 1999–2007. Am J Trop Med Hyg 86: 713–719.
-
6.
Childs JE, Paddock CD, 2002. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg 66: 450–457.
-
7.
Regan JJ, et al., 2015. Risk factors for fatal outcome from Rocky Mountain spotted fever in highly endemic area: Arizona, 2002–2011. Clin Infect Dis 60: 1659–1666.
-
8.
La Scola B, Raoult D, 1997. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 35: 2715–2727.
-
9.
Delisle J, Mendell NL, Stull-Lane A, Bloch KC, Bouyer DH, Moncayo AC, 2016. Human infections by multiple spotted fever group rickettsiae in Tennessee. Am J Trop Med Hyg 94: 1212–1217.
-
10.
Council of State and Territorial Epidemiologists, 2009. Position Statement: Public Health Reporting and National Notification for Spotted Fever Rickettsiosis (including Rocky Mountain spotted fever). Available at: http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/PS/09-ID-16.pdf. Accessed August 17, 2016.
-
11.
Centers for Disease Control and Prevention, 2010. Spotted Fever Rickettsiosis (Rickettsia spp.): 2010 Case Definition. Available at: https://wwwn.cdc.gov/nndss/conditions/spotted-fever-rickettsiosis/case-definition/2010/. Accessed August 31, 2016.
-
12.
Tennessee Department of Health, 2015. Reportable Diseases. Available at: https://apps.health.tn.gov/ReportableDiseases/ReportingOverview.aspx. Accessed August 17, 2016.
-
13.
Tennessee Department of Health Reportable Diseases and Events, 2012. PH-1600. Available at: https://tn.gov/assets/entities/health/attachments/ph-1600.pdf. Accessed August 17, 2016.
-
14.
Centers for Disease Control and Prevention, 2015. National Notifiable Diseases Surveillance System (NNDSS). Available at: https://wwwn.cdc.gov/nndss/nedss.html. Accessed August 17, 2016.
-
15.
Ivey KS, Pruthi S, Bloch KC, 2014. Neurologic manifestations of Rocky Mountain spotted fever in children and adults. Open Forum Infect Dis 1: S241.
-
16.
Marshall GS, et al., 2003. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med 157: 443–448.
-
17.
Centers for Disease Control and Prevention, 2010. Rocky Mountain Spotted Fever: Symptoms, Diagnosis, and Treatment. Available at: http://www.cdc.gov/rmsf/symptoms/.Accessed December 8, 2016.
-
18.
Raoult D, Parola P, 2008. Rocky Mountain spotted fever in the USA: a benign disease or a common diagnostic error? Lancet Infect Dis 8: 587–589.
-
19.
Dahlgren FS, Paddock CD, Springer YP, Eisen RJ, Behravesh CB, 2016. Expanding range of Amblyomma americanum and simultaneous changes in the epidemiology of spotted fever group rickettsiosis in the United States. Am J Trop Med Hyg 94: 35–42.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 373 | 323 | 13 |
| Full Text Views | 330 | 8 | 0 |
| PDF Downloads | 84 | 8 | 0 |
Evaluation of a Spotted Fever Group Rickettsia Public Health Surveillance System in Tennessee
Mary-Margaret A. Fill
Mary-Margaret A. Fill
Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, Georgia
Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, Tennessee
Search for other papers by Mary-Margaret A. Fill in
Current site
Google Scholar
PubMed
Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, Tennessee
Search for other papers by Mary-Margaret A. Fill in
Current site
Google Scholar
PubMed
Abelardo C. Moncayo
Abelardo C. Moncayo
Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, Tennessee
Search for other papers by Abelardo C. Moncayo in
Current site
Google Scholar
PubMed
Search for other papers by Abelardo C. Moncayo in
Current site
Google Scholar
PubMed
Karen C. Bloch
Karen C. Bloch
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee
Search for other papers by Karen C. Bloch in
Current site
Google Scholar
PubMed
Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee
Search for other papers by Karen C. Bloch in
Current site
Google Scholar
PubMed
John R. Dunn
John R. Dunn
Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, Tennessee
Search for other papers by John R. Dunn in
Current site
Google Scholar
PubMed
Search for other papers by John R. Dunn in
Current site
Google Scholar
PubMed
William Schaffner
William Schaffner
Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee
Search for other papers by William Schaffner in
Current site
Google Scholar
PubMed
Search for other papers by William Schaffner in
Current site
Google Scholar
PubMed
Timothy F. Jones
Timothy F. Jones
Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, Tennessee
Search for other papers by Timothy F. Jones in
Current site
Google Scholar
PubMed
Search for other papers by Timothy F. Jones in
Current site
Google Scholar
PubMed
Spotted fever group (SFG) rickettsioses are endemic in Tennessee, with ∼2,500 cases reported during 2000–2012. Because of this substantial burden of disease, we performed a three-part evaluation of Tennessee's routine surveillance for SFG rickettsioses cases and deaths to assess the system's effectiveness. Tennessee Department of Health (TDH) SFG rickettsioses surveillance records were matched to three patient series: 1) patients with positive serologic specimens from a commercial reference laboratory during 2010–2011, 2) tertiary medical center patients with positive serologic tests during 2007–2013, and 3) patients identified from death certificates issued during 1995–2014 with SFG rickettsiosis–related causes of death. Chart reviews were performed and patients were classified according to the Council of State and Territorial Epidemiologists' case definition. Of 254 SFG Rickettsia–positive serologic specimens from the reference laboratory, 129 (51%) met the case definition for confirmed or probable cases of rickettsial disease after chart review. The sensitivity of the TDH surveillance system to detect cases was 45%. Of the 98 confirmed or probable cases identified from the medical center, the sensitivity of the TDH surveillance system to detect cases was 34%. Of 27 patients identified by death certificates, 12 (44%) were classified as confirmed or probable cases; four (33%) were reported to TDH, but none were correctly identified as deceased. Cases of SFG rickettsioses were underreported and fatalities not correctly identified. Efforts are needed to improve SFG rickettsiosis surveillance in Tennessee.
Author Notes
Authors' addresses: Mary-Margaret A. Fill, Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, GA, and Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, TN, E-mail: mary-margaret.fill@tn.gov. Abelardo C. Moncayo, John R. Dunn, and Timothy F. Jones, Division of Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville, TN, E-mails: abelardo.moncayo@tn.gov, john.dunn@tn.gov, and tim.f.jones@tn.gov. Karen C. Bloch, Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, and Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, E-mail: karen.bloch@vanderbilt.edu. William Schaffner, Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, E-mail: william.schaffner@vanderbilt.edu.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Dantas-Torres F, 2007. Rocky Mountain spotted fever. Lancet Infect Dis 150: 480–488.
-
2.
Tennessee Department of Health, 2016. Reportable Diseases and Events Matrix. Available at: https://apps.health.tn.gov/ReportableDiseases/Common/Updated_ReportableDiseasesMatrix_160203.pdf. Accessed July 28, 2016.
-
3.
Drexler NA, Dahlgren FS, Heitman KN, Massung RF, Paddock CD, Behravesh CB, 2016. National surveillance of spotted fever group rickettsioses in the United States, 2008–2012. Am J Trop Med Hyg 94: 26–34.
-
4.
Openshaw JJ, Swerdlow DL, Krebs JW, Holman RC, Mandel E, Harvey A, Haberling D, Massung RF, McQuiston JH, 2010. Rocky Mountain spotted fever in the United States, 2000–2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg 83: 174–182.
-
5.
Dahlgren FS, Holman RC, Paddock CK, Callinan LS, McQuiston JH, 2012. Fatal Rocky Mountain spotted fever in the United States, 1999–2007. Am J Trop Med Hyg 86: 713–719.
-
6.
Childs JE, Paddock CD, 2002. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg 66: 450–457.
-
7.
Regan JJ, et al., 2015. Risk factors for fatal outcome from Rocky Mountain spotted fever in highly endemic area: Arizona, 2002–2011. Clin Infect Dis 60: 1659–1666.
-
8.
La Scola B, Raoult D, 1997. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 35: 2715–2727.
-
9.
Delisle J, Mendell NL, Stull-Lane A, Bloch KC, Bouyer DH, Moncayo AC, 2016. Human infections by multiple spotted fever group rickettsiae in Tennessee. Am J Trop Med Hyg 94: 1212–1217.
-
10.
Council of State and Territorial Epidemiologists, 2009. Position Statement: Public Health Reporting and National Notification for Spotted Fever Rickettsiosis (including Rocky Mountain spotted fever). Available at: http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/PS/09-ID-16.pdf. Accessed August 17, 2016.
-
11.
Centers for Disease Control and Prevention, 2010. Spotted Fever Rickettsiosis (Rickettsia spp.): 2010 Case Definition. Available at: https://wwwn.cdc.gov/nndss/conditions/spotted-fever-rickettsiosis/case-definition/2010/. Accessed August 31, 2016.
-
12.
Tennessee Department of Health, 2015. Reportable Diseases. Available at: https://apps.health.tn.gov/ReportableDiseases/ReportingOverview.aspx. Accessed August 17, 2016.
-
13.
Tennessee Department of Health Reportable Diseases and Events, 2012. PH-1600. Available at: https://tn.gov/assets/entities/health/attachments/ph-1600.pdf. Accessed August 17, 2016.
-
14.
Centers for Disease Control and Prevention, 2015. National Notifiable Diseases Surveillance System (NNDSS). Available at: https://wwwn.cdc.gov/nndss/nedss.html. Accessed August 17, 2016.
-
15.
Ivey KS, Pruthi S, Bloch KC, 2014. Neurologic manifestations of Rocky Mountain spotted fever in children and adults. Open Forum Infect Dis 1: S241.
-
16.
Marshall GS, et al., 2003. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med 157: 443–448.
-
17.
Centers for Disease Control and Prevention, 2010. Rocky Mountain Spotted Fever: Symptoms, Diagnosis, and Treatment. Available at: http://www.cdc.gov/rmsf/symptoms/.Accessed December 8, 2016.
-
18.
Raoult D, Parola P, 2008. Rocky Mountain spotted fever in the USA: a benign disease or a common diagnostic error? Lancet Infect Dis 8: 587–589.
-
19.
Dahlgren FS, Paddock CD, Springer YP, Eisen RJ, Behravesh CB, 2016. Expanding range of Amblyomma americanum and simultaneous changes in the epidemiology of spotted fever group rickettsiosis in the United States. Am J Trop Med Hyg 94: 35–42.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 373 | 323 | 13 |
| Full Text Views | 330 | 8 | 0 |
| PDF Downloads | 84 | 8 | 0 |